SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Novavax, Inc.

Novavax Inc

Novavaxs quarterly results and higher full-year revenue outlook, supported by a Sanofi milestone, are driving attention even as the shares sell off. Traders are split between viewing the licensing model and partner payments as proof of improving finances and worrying about reliance on milestones, delayed profitability and a lack of additional deals or pipeline data.

NVIDIA Corp. engages in the design and manufacture of computer graphics processors, chipsets, and related multimedia software. It operates through the following segments: Graphics Processing Unit (GPU) and Compute & Networking. The Graphics segment includes GeForce GPUs for gaming and PCs, the GeForce NOW game streaming service and related infrastructure, Quadro and NVIDIA RTX GPUs for enterprise workstation graphics, virtual GPU, or vGPU, software for cloud-based visual and virtual computing, automotive platforms for infotainment systems, and Omniverse Enterprise software for building and operating metaverse and 3D internet applications. The Compute & Networking segment consists of Data Center accelerated computing platforms and end-to-end networking platforms including Quantum for InfiniBand and Spectrum for Ethernet, NVIDIA DRIVE automated-driving platform and automotive development agreements, Jetson robotics and other embedded platforms, NVIDIA AI Enterprise and other software, and DGX Cloud software and services. The company was founded by Jen Hsun Huang, Chris A. Malachowsky, and Curtis R. Priem in April 1993 and is headquartered in Santa Clara, CA.

NVIDIA Corp

A sharp semiconductor selloff is tied to traders concerns that post-election calls for tighter oversight or pauses on data-center construction could slow AI infrastructure spending and weaken chip demand. The community is split between seeing the drop as an overreaction and buying opportunity, and warning that even a slowdownnot a haltin AI buildout could pressure the sector.

Bitcoin (BTC) is a cryptocurrency launched in 2010. Users are able to generate BTC through the process of mining. Bitcoin has a current supply of 20,105,365. The last known price of Bitcoin is 76,098.29866033 USD and is down -5.65 over the last 24 hours. It is currently trading on 12776 active market(s) with $48,501,391,251.88 traded over the last 24 hours. More information can be found at https://bitcoin.org/.

Bitcoin

Bitcoins sharp decline is being discussed alongside a broader risk-off selloff in tech and crypto, with traders noting its tendency to move with equities. The community is split between warnings of a deeper breakdown and dip buyers arguing the pullback is overdone and support may hold.

Cloudflare, Inc. engages in the provision of cloud-based services to secure websites. The firm offers various products for application security, performance and reliability, network services, Zero Trust, developer platform, media delivery, insights, domain registration, and consumer services. It operates through the United States and Rest of the World geographical segments. The company was founded by Matthew Prince, Michelle Zatlyn, and Lee Holloway in July 2009 and is headquartered in San Francisco, CA.

Cloudflare Inc - Ordinary Shares - Class A

Cloudflare Inc

Cloudflares quarterly earnings beat and raised outlook sparked a sharp after-hours rally, even as shares fell during the regular session amid a broader tech selloff. Traders are weighing accelerating growth against the stocks high valuation, margin pressure and ongoing profitability concerns.

Xeris Biopharma Holdings, Inc. is a biopharmaceutical company, which engages in developing and commercializing products across a range of therapies. Its products include Gvoke, Keveyis, and Recorlev. Gvoke is a ready-to-use liquid glucagon for the treatment of severe hypoglycemia. Keveyis is the therapy approved in the United States to treat hyperkalemic, hypokalemic, and related variants of primary periodic paralysis (PPP). Recorlev is a cortisol synthesis inhibitor approved for the treatment of endogenous hypercortisolemia in adult patients with Cushing’s syndrome. The company was founded by Steven Prestrelski in 2005 and is headquartered in Chicago, IL.

Xeris Biopharma Holdings Inc

Xeris strong Q3 results, rapid Recorlev growth and raised revenue outlook are driving the rally, with investors focused on the drugs faster-than-expected path toward blockbuster sales. The community is broadly bullish, though takeover talk remains speculation and some traders caution about volatility and profit-taking.

Lyft, Inc. engages in the provision and management of an online social rideshare community platform. It offers access to a network of shared bikes and scooters for shorter rides and first mile and last-mile legs of multimodal trips, information about nearby public transit routes, and Lyft Rentals to offer riders a view of transportation options when planning any trip. The company was founded by Marcus Cohn, John Zimmer, Rajat Suri, Matt van Horn, and Logan D. Green on March 5, 2007 and is headquartered in San Francisco, CA.

Lyft Inc - Ordinary Shares Cls A

Lyft Inc

Lyft is drawing attention after quarterly results missed revenue and earnings expectations, with legal, tax and regulatory reserves weighing on reported results. Traders are split between focusing on the headline miss and selloff versus stronger bookings, rider growth, adjusted profitability and upbeat forward guidance.

Lockheed Martin Corp. is a global security and aerospace company, which engages in the research, design, development, manufacture, integration, and sustainment of technology systems, products, and services. It operates through the following business segments: Aeronautics, Missiles and Fire Control (MFC), Rotary and Mission Systems (RMS), and Space. The Aeronautics segment researches, designs, develops, manufactures, integrates, sustains, supports, and upgrades advanced military aircraft, including combat and air mobility aircraft, unmanned air vehicles, and related technologies. The MFC segment is involved in air and missile defense systems, tactical missiles and air-to-ground precision strike weapon systems, logistics, fire control systems, mission operations support, readiness, engineering support and integration services, manned and unmanned ground vehicles, and energy management solutions. The RMS segment designs, manufactures, services, and supports various military and commercial helicopters, surface ships, sea and land-based missile defense systems, radar systems, sea and air-based mission and combat systems, command and control mission solutions, cyber solutions, and simulation and training solutions. The Space segment includes the production of satellites, space transportation systems, and strategic, advanced strike, and defensive systems. The company was founded in 1995 and is headquartered in Bethesda, MD.

Lockheed Martin Corp.

Lockheed Martin is drawing attention as its shares slide alongside defense stocks, with traders linking the weakness to political uncertainty and concerns that a Democratic-controlled Congress could constrain Pentagon spending. Bulls argue that the companys execution and long-term backlog remain intact, while bears focus on the risk of tighter budgets.

Ethereum (ETH) is a cryptocurrency . Ethereum has a current supply of 122,192,071.85523712. The last known price of Ethereum is 2,238.82507201 USD and is down -7.69 over the last 24 hours. It is currently trading on 14268 active market(s) with $19,113,383,798.40 traded over the last 24 hours. More information can be found at https://www.ethereum.org/.

Ethereum

Ethereum is drawing attention after a sharp selloff alongside broad weakness in crypto, with traders split between buying the dip and expecting further downside. Some cite the Binance hack and election-related regulatory uncertainty as added risks, while others argue the decline is a shakeout and expect a rebound.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IonQs quarterly results and raised revenue outlook are drawing attention, with traders citing strong growth and backlog despite a sharp share-price decline. The reaction is split: bulls view the report as evidence of demand, while skeptics focus on dilution, cash burn, revenue quality and broader market weakness.

Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce. Its platform consists of three core elements: a point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. The company was founded by Max R. Levchin in 2012 and is headquartered in San Francisco, CA.

Affirm Holdings Inc - Ordinary Shares - Class A

Affirm Holdings Inc

Affirms earnings beat expectations, but shares sold off as traders focused on worsening consumer-credit indicators, including rising delinquencies and loan losses. The community is split between viewing the reaction as an overdone sell-the-news move and worrying that weaker credit quality could pressure profitability.

statis crypto Watchlist

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

$BBIO is going against $PFE and doing well
$TGTX  against Roche .::  and others 
For $VKTX is much easier as consumer driven.. news spread like 🔥 . If they offer something $50 cheaper then $LLY they could take 20% of Lilly business.  
They will be limited by supply and this is why BI cut deals with 4 sources. 
I can’t see Lilly just watching at the end.  ..

TopOptionsAlerts®

BioSwings™

Ronald Baker

Ashley Thomas

Your favorite Viking investor.

Michael

lol fair question. the bear case people actually make is pretty simple. no phase 3 data til 2027 and going up against Lilly and Novo scale on commercial. that is the whole put thesis imo. but the data so far is the other side of it. 14.7% at 13 weeks on the shot, oral Sunrise phase 3 just started, Vanquish fully enrolled with about 5600 patients. cash around 960M too. so yeah the worry is real but it is a timing and scale worry, not a data worry

StockTwits Web

StockTwits for iOS

BridgeBio Pharma Inc

Pfizer Inc

TG Therapeutics Inc

Viking Therapeutics Inc

Lilly(Eli) & Co

 is much easier as consumer driven.. news spread like 🔥 . If they offer something $50 cheaper then 

 they could take 20% of Lilly business.  
They will be limited by supply and this is why BI cut deals with 4 sources. 
I can’t see Lilly just watching at the end.  ..

Biolover

Yeah the consumer angle is the part I keep coming back to on $VKTX too. Price is the edge if the data keeps delivering, and the clock is what I am watching. Oral SUNRISE kicked off Oct 14, VANQUISH is fully enrolled with the primary read Jul 2027, and they have ObesityWeek posters Nov 14 and 15. The money on this name gets made in the runup, not on the headline. I post my full plan for it at https://bioswings.com

If you love money, you'll love BioSwings VIP: biotech stock and options alerts with entry, stop, targets, live trims and exits, and an FDA catalyst calendar. Try 3 VIP trading sessions free on Telegram.

Bioswings

BioSwings VIP · If you love money, you'll love our biotech alerts

Yeah the consumer angle is the part I keep coming back to on 

 too. Price is the edge if the data keeps delivering, and the clock is what I am watching. Oral SUNRISE kicked off Oct 14, VANQUISH is fully enrolled with the primary read Jul 2027, and they have ObesityWeek posters Nov 14 and 15. The money on this name gets made in the runup, not on the headline. I post my full plan for it at 